. Author manuscript; available in PMC: 2014 Feb 1.

Published in final edited form as: Biol Blood Marrow Transplant. 2012 Nov 27;19(2):173–179. doi: 10.1016/j.bbmt.2012.11.016

Table 2.

Outcomes after HCT for BL

	Autologous (N =113)	HLA-identical siblings (N=80)	Unrelated/ mismatched related (N=48)

Outcome event	Prob (95% CI)	Prob (95% CI)	Prob (95% CI)	P-value^a
100 day mortality	4 (1–8)	20 (12–30)	19 (9–31)	<0.001
Acute GVHD @ 100 days, grades (2–4)	NA	35 (25–46)	53 (39–67)	0.044
Acute GVHD @ 100 days, grades (3–4)	NA	15 (8–24)	35 (23–49)	0.010
Chronic GVHD	NA
@ 1 year		17 (9–26)	16 (7–28)	0.873
@ 3 years		18 (10–28)	16 (7–28)	0.734
@ 5 years		18 (10–28)	16 (7–28)	0.734

Abbreviations ANC = neutrophil recovery; TRM = treatment-related mortality; PFS = progression-free survival; PROB = probability; CI = confidence interval.